• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Celestica

Celestica

Celestica Inc CLS

Last Price$10.75Day Change (%)-0.83%
Open Price$10.87Day Change ($)-0.09
Day Range10.70–10.8752-Week Range7.60–11.50

As of Thu 04/17/2014 03:16 PM EST | USD

  1. Emerging Markets Equity Commentary – September 2013

    Celestica CLS announced president Craig Muhlhauser will be taking over as CEO for the Toronto-based contract manufacturer. Muhlhauser will replace Stephen Delaney, who resigned his position to pursue other business interests. After years of operational missteps, we are cautiously optimistic ...

  2. Can Manufacturing Keep Stocks Afloat?

    Celestica CLS Tuesday warned that revenues for the fourth quarter would be lower than previously estimated. We are maintaining our fair value estimate for now but will continue to monitor the firm's ham-handed recovery. Management noted weak demand from its largest customers in the communications ...

  3. CLS Investments Launches Practice Management Program

    Third-party money manager CLS Investments announced the launch of a new multimedia educational initiative for financial advisors on Monday.

  4. CLS : Time to Get Nervous?

    PACCAR PCAR reported its best-ever annual results on Tuesday, and although revenues and general industry trends are playing out as we expected, we are increasing our fair value estimate for the company to $70 per share from $61. There are four reasons for this increase. First, we are crediting ...

  5. CLS : Does January Set the Tone for the Year?

    Demand for network capacity to and from Asia, particularly across the Pacific, has increased steadily over the past year, benefiting the owners of relatively scarce undersea capacity in the region. As the owner of the former Tyco Global Network--which currently carries more than a third of ...

  6. CLS : Stay Awake: Drowsy Investing is Never Good

    Keryx is focused on renal disease drug candidate Sulonex, but its cancer pipeline is also growing.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.